CYP1A2's role in weight loss is indirect, primarily through caffeine metabolism. CYP1A2 is the main enzyme breaking down caffeine. Caffeine can transiently boost metabolism and fat oxidation, but the effect is modest and highly individual. Slow metabolizers (e.g., CYP1A2*1F variants) may experience stronger side effects like insomnia or jitters, which can hinder consistent diet and exercise. No strong evidence links CYP1A2 variants directly to weight loss success. The evidence is mostly mechanistic; human studies are mixed and often confounded by lifestyle factors. For sustainable weight loss, calorie deficit, physical activity, and sleep hygiene are far more impactful than this single gene. Caution: high caffeine intake can lead to tolerance, anxiety, and cardiovascular strain. Do not rely on genetic tests for weight loss advice without considering overall context.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-81160dde8360d910c9136965